top of page
Search

TimeX Capital Bolsters Healthcare Leadership with Appointment of Dr. Gopal Chopra, MD, FRACS, MBA

  • Oct 15, 2025
  • 2 min read


WASHINGTON, DC October 15, 2025 – TimeX Capital, a forward-thinking investment bank dedicated to high-growth and innovation-driven industries, proudly announces the appointment of Dr. Gopal Chopra as Strategic Advisor - Healthcare. This strategic addition underscores TimeX Capital’s commitment to deepening its expertise in BioTech, MedTech, and healthtech innovation.


Dr. Chopra brings over three decades of unparalleled experience as a neurosurgeon, entrepreneur, and strategic advisor in the healthcare sector. With a distinguished career spanning medical devices, diagnostics, healthtech, and pharmaceuticals, he has guided both early-stage startups and large-cap companies through transformative growth, strategic deals, and operational excellence. As co-founder and managing partner of TCG, an executive accelerator focused on smart and personalized medical and wellness technologies, Dr. Chopra has a proven track record of fostering innovation at the cutting edge of healthcare.


His extensive advisory experience includes high-profile transactions such as the $2B sale of Arrow to Teleflex, the $1.5B acquisition of Viasys by Cardinal Health, the $167M sale of Hemosense to Inverness, and the $117M acquisition of BioArray Solutions by Immucor. Dr. Chopra’s expertise in mergers and acquisitions, IPOs, PIPEs, and private financings has enabled numerous transformative deals across developed and emerging markets.


A globally recognized neurosurgeon, Dr. Chopra has practiced in Australia, India, Canada, and the United States, holding faculty appointments at prestigious institutions including Stanford University, Duke University, and the University of Melbourne. As an Associate Professor at Duke University’s Fuqua School of Business, he has been an invited expert in neuroscience, neurosurgery, robotics, and neurocognition, contributing to advancements in these fields.



Dr. Gopal Chopra, MD, FRACS, MBA
Dr. Gopal Chopra, MD, FRACS, MBA

Dr. Chopra holds a medical degree from the University of Melbourne (1989), a Diploma in Anatomy from the Anatomical Society of Australia and New Zealand (1992), a fellowship in neurosurgery from the Royal Australasian College of Surgeons (1999), and an MBA with a health sector management certificate from Duke University’s Fuqua School of Business (2003).






"Joining TimeX Capital aligns perfectly with my passion for driving healthcare innovation through strategic partnerships and transformative financial solutions. TimeX’s commitment to empowering founders and leveraging intellectual property to create long-term value resonates deeply with my vision. I look forward to working with The TimeX Capital Board and Leadership team  to accelerate the growth of pioneering BioTech, MedTech, and Healthtech clients, bringing cutting-edge solutions to market."

– Dr. Gopal Chopra, MD, FRACS, MBA,          


"We are honored to welcome Dr. Gopal Chopra to TimeX Capital’s Healthcare team. His remarkable expertise as a neurosurgeon, entrepreneur, and strategic advisor, combined with his proven success in guiding high-impact transactions, positions him as an invaluable asset to our firm and our clients. Dr.Chopra’s global perspective and dedication to advancing healthcare innovation align seamlessly with our mission to redefine investment banking. With his leadership, we are well-equipped to empower the next wave of healthcare innovators to achieve transformative outcomes."

– Arun Subramony, TimeX Chairman & CEO


About TimeX Capital LLC

TimeX Capital LLC is a pioneering investment banking firm that redefines the traditional model by prioritizing Time as the most critical stakeholder. Dedicated to serving founders and entrepreneurs in Healthcare, Sustainable Infrastructure, and Digital Intelligence, TimeX focuses on long-term value creation through a skin-in-the-game approach. By leveraging its expertise in aggregating, valuing, and monetizing IP assets, TimeX transforms companies globally, delivering unparalleled impact in high-growth industries.

 
 

Securities are offered through Finalis Securities LLC Member FINRA / SIPC.  TimeX Capital LLC is not a registered broker-dealer, and Finalis Securities LLC and TimeX Capital LLC are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.

Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary (“Form CRS”)

timexcapital.com (the "TimeX Capital LLC Website") is a website operated by TimeX Capital LLC. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and TimeX Capital LLC along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.

Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.

bottom of page